As few Contract Development and Manufacturing Organizations (CDMOs) offer the specialized, niche services needed to manufacture small scale cGMP OINDPs for clinical trials, finding the right manufacturer with both the capabilities and available capacity for your product can be challenging. Manufacturing your clinical trial materials (CTMs) efficiently in your chosen nasal or inhalation drug delivery system is critical to keeping your clinical study on track. Nanopharm makes this process simple for customers.  We work with a select number of qualified specialist CDMOs, with the right experience and cGMP OINDP manufacturing capabilities to meet your early phase clinical supply needs. Nanopharm manages the technical transfer to the established CDMO partner, ensuring a smooth and rapid process that reduces the number of third parties you need to manage. And that means you don’t have to worry about program delays caused by long queues for production slots or having to spend money on manufacturing batches larger than you need because of mismatched capacity requirements.  Nanopharm brings you the right pre-qualified CDMO, so you can get on with your important clinical study sooner.